Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

Por Ciprero, Karen, Zykov, Kirill A., Briko, Nikolay I., Shekar, Tulin, Sterling, Tina M., Bitieva, Elizaveta, Stek, Jon E., Musey, Luwy
Publicado no Hum Vaccin Immunother (2016)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-...

Por Peterson, James T., Stacey, Helen L., MacNair, John E., Li, Jianing, Hartzel, Jonathan S., Sterling, Tina M., Benner, Patrice, Tamms, Gretchen M., Musey, Luwy K.
Publicado no Hum Vaccin Immunother (2018)

Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

Por Ciprero, Karen L., Marchese, Rocio D., Richard, Patrick, Baudin, Martine, Sterling, Tina M., Manoff, Susan B., Radley, David, Stek, Jon E., Soubeyrand, Benoît, Grabenstein, John D., Samson, Sandrine I., Musey, Luwy K.
Publicado no Hum Vaccin Immunother (2016)

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal...

Por Buchwald, Ulrike, Peterson, James, Stacey, Helen, Julien, Katie, Sterling, Tina, Bruch, Melanie, Tamms, Gretchen, Li, Jianing, Pedley, Alison, Nolan, Katrina, Benner, Patrice, Abeygunawardana, Chitrananda, Winters, Michael, Kosinski, Michael, Stek, Jon, Musey, Luwy
Publicado no Open Forum Infect Dis (2018)

A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax

Por Gilderman, Larry I., Lawless, James F., Nolen, Thomas M., Sterling, Tina, Rutledge, Ruth Z., Fernsler, Doreen A., Azrolan, Neal, Sutradhar, Santosh C., Wang, William W., Chan, Ivan S. F., Schlienger, Katia, Schödel, Florian, Silber, Jeffrey L.
Publicado em 2008

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Por Stacey, Helen L., Rosen, Jeffrey, Peterson, James T., Williams-Diaz, Angela, Gakhar, Vanita, Sterling, Tina M., Acosta, Camilo J., Nolan, Katrina M., Li, Jianing, Pedley, Alison, Benner, Patrice, Abeygunawardana, Chitrananda, Kosinski, Michael, Smith, William J., Pujar, Hari, Musey, Luwy K.
Publicado no Hum Vaccin Immunother (2019)